豚鼠对灭活的Ⅰ期伯纳特柯克斯体疫苗的细胞介导免疫反应。
Cell-mediated immune responses of guinea pigs to an inactivated phase I Coxiella burnetii vaccine.
作者信息
Kishimoto R A, Johnson J W, Kenyon R H, Ascher M S, Larson E W, Pedersen C E
出版信息
Infect Immun. 1978 Jan;19(1):194-8. doi: 10.1128/iai.19.1.194-198.1978.
Abstract
The ability of a killed phase I Coxiella burnetii vaccine to induce cell-mediated immune responses in guinea pigs was studied. Cell-mediated immune responses were assessed by the inhibition of macrophage migration and lymphocyte transformation assays. The macrophage migration response occurred rapidly and was detected at high levels, but was relatively short-lived. In contrast, the lymphocyte transformation response developed more slowly, and persisted for a longer period. The vaccine, given in a single dose or in two doses 1 week apart, protected guinea pigs from a subsequent virulent challenge.
摘要
研究了灭活的Ⅰ期伯纳特柯克斯体疫苗在豚鼠中诱导细胞介导免疫反应的能力。通过巨噬细胞迁移抑制试验和淋巴细胞转化试验评估细胞介导的免疫反应。巨噬细胞迁移反应迅速发生且水平较高，但持续时间相对较短。相比之下，淋巴细胞转化反应发展较慢，但持续时间更长。单剂量或间隔1周分两剂接种的疫苗可保护豚鼠免受随后的强毒株攻击。
相似文献
1
Cell-mediated immune responses of guinea pigs to an inactivated phase I Coxiella burnetii vaccine.
Infect Immun. 1978 Jan;19(1):194-8. doi: 10.1128/iai.19.1.194-198.1978.
2
Effect of lysozyme on the immune response of guinea pigs to the soluble phase 1 antigen of Coxiella burnetii.
Acta Virol. 1981 Jul;25(4):241-4.
3
Appearance of cellular and humoral immunity in guinea pigs after infection with Coxiella burnetii administered in small-particle aerosols.
Infect Immun. 1977 May;16(2):518-21. doi: 10.1128/iai.16.2.518-521.1977.
4
[Humoral immune response of goats, rabbits and guinea pigs following vaccination with a Q fever vaccine].
Berl Munch Tierarztl Wochenschr. 1985 Jan 1;98(1):20-4.
5
Vaccines against coxiellosis and Q fever. Development of a chloroform:methanol residue subunit of phase I Coxiella burnetti for the immunization of animals.
Ann N Y Acad Sci. 1992 Jun 16;653:88-111. doi: 10.1111/j.1749-6632.1992.tb19633.x.
6
Enhancement of the immunogenicity of phase I antigen of Coxiella burnetii.
Infect Immun. 1978 Nov;22(2):627-8. doi: 10.1128/iai.22.2.627-628.1978.
7
Vaccine prophylaxis of abattoir-associated Q fever: eight years' experience in Australian abattoirs.
Epidemiol Infect. 1990 Apr;104(2):275-87. doi: 10.1017/s0950268800059458.
8
Humoral immune response to Q fever: enzyme-linked immunosorbent assay antibody response to Coxiella burnetii in experimentally infected guinea pigs.
J Clin Microbiol. 1986 Dec;24(6):935-9. doi: 10.1128/jcm.24.6.935-939.1986.
9
Comparative efficacy of a Coxiella burnetii chloroform:methanol residue (CMR) vaccine and a licensed cellular vaccine (Q-Vax) in rodents challenged by aerosol.
Vaccine. 1997 Nov;15(16):1779-83. doi: 10.1016/s0264-410x(97)00107-2.
10
Search for correlates of resistance to virulent challenge in mice immunized with Coxiella burnetii.
Acta Virol. 1977 Sep;21(5):422-30.
引用本文的文献
1
Q fever immunology: the quest for a safe and effective vaccine.
NPJ Vaccines. 2023 Sep 7;8(1):133. doi: 10.1038/s41541-023-00727-6.
2
Q Fever Vaccine Development: Current Strategies and Future Considerations.
Pathogens. 2021 Sep 22;10(10):1223. doi: 10.3390/pathogens10101223.
3
Chemokine Receptor 7 Is Essential for Coxiella burnetii Whole-Cell Vaccine-Induced Cellular Immunity but Dispensable for Vaccine-Mediated Protective Immunity.
J Infect Dis. 2019 Jul 19;220(4):624-634. doi: 10.1093/infdis/jiz146.
4
Host and Bacterial Factors Control Susceptibility of Drosophila melanogaster to Coxiella burnetii Infection.
Infect Immun. 2017 Jun 20;85(7). doi: 10.1128/IAI.00218-17. Print 2017 Jul.
5
Animal models of Q fever (Coxiella burnetii).
Comp Med. 2013;63(6):469-76.
6
Cloning and porin activity of the major outer membrane protein P1 from Coxiella burnetii.
Infect Immun. 2002 Dec;70(12):6741-50. doi: 10.1128/IAI.70.12.6741-6750.2002.
7
Safety and immunogenicity in human volunteers of a chloroform-methanol residue vaccine for Q fever.
Infect Immun. 1993 Apr;61(4):1251-8. doi: 10.1128/iai.61.4.1251-1258.1993.
8
Mechanisms of protective immunogenicity of microbial vaccines: effects of cyclophosphamide pretreatment in Venezuelan encephalitis, Q fever and tularaemia.
Clin Exp Immunol. 1980 Aug;41(2):225-36.
9
Role of antibody in Coxiella burnetii infection.
Infect Immun. 1981 Feb;31(2):641-5. doi: 10.1128/iai.31.2.641-645.1981.
10
Biological and immunological properties of Coxiella burnetii vaccines in C57BL/10ScN endotoxin-nonresponder mice.
Infect Immun. 1982 Mar;35(3):1091-102. doi: 10.1128/iai.35.3.1091-1102.1982.
本文引用的文献
1
Q fever in California. I. Observations on vaccination of human beings.
Am J Hyg. 1950 Jul;52(1):54-64.
2
THE INFLUENCE OF PHASE ON THE PROTECTIVE POTENCY OF Q FEVER VACCINE.
J Immunol. 1964 Mar;92:404-12.
3
Serological diagnosis of scrub typhus by indirect immunofluorescence.
Proc Soc Exp Biol Med. 1963 Mar;112:568-73. doi: 10.3181/00379727-112-28107.
4
Protective or neutralizing antibody in Q fever.
Am J Hyg. 1957 Sep;66(2):173-95. doi: 10.1093/oxfordjournals.aje.a119894.
5
Studies on Q fever in man.
Trans Assoc Am Physicians. 1956;69:98-104.
6
Alterations of macrophage functions by mediators from lymphocytes.
J Exp Med. 1971 Jun 1;133(6):1356-76. doi: 10.1084/jem.133.6.1356.
7
Lymphocyte transformation in rickettsioses.
J Immunol. 1971 Jan;106(1):209-16.
8
Modulation of in vitro lymphocyte transformation by antibodies: enhancement by antigen-antibody complexes and inhibition by antibody excess.
Cell Immunol. 1972 Mar;3(3):341-60. doi: 10.1016/0008-8749(72)90243-2.
9
Production of a potent vaccine from the attenuated M-44 strain of Coxiella burneti.
Appl Microbiol. 1974 Apr;27(4):777-83. doi: 10.1128/am.27.4.777-783.1974.
10
A microagglutination technique for detection and measurement of rickettsial antibodies.
Acta Virol. 1969 Jan;13(1):60-6.
Zotero 插件